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ABSTRACT
Although the UK National Institute for Health and Care
Excellence guidelines recommend that in patients with
biopsy-proven invasive lobular carcinoma (ILC),
preoperative MRI scan is considered, the accuracy of
diagnosis of ILC in core biopsy of the breast has not
been previously investigated. Eleven pathology
laboratories from the UK and Ireland submitted data on
1112 cases interpreted as showing features of ILC, or
mixed ILC and IDC/no special type (NST)/other tumour
type, on needle core biopsy through retrieval of histology
reports. Of the total 1112 cases, 844 were shown to be
pure ILC on surgical excision, 154 were mixed ILC plus
another type (invariably ductal/NST) and 113 were
shown to be ductal/NST. Of those lesions categorised as
pure ILC on core, 93% had an element of ILC correctly
identiﬁed in the core biopsy sample and could be
considered concordant. Of cores diagnosed as mixed ILC
plus another type on core, complete agreement between
core and excision was 46%, with 27% cases of pure
ILC, whilst 26% non-concordant. These data indicate
that there is not a large excess of expensive MRIs being
performed as a result of miscategorisation histologically.
INTRODUCTION
Deﬁning histological subtype of invasive breast
cancer on needle core biopsies informs the subse-
quent radiological and clinical management of
patients. Speciﬁcally, the National Institute for
Health and Care Excellence’s (NICE) guidelines,
'Early and locally advanced breast cancer: diagnosis
and treatment' [CG80], recommend that in patients
with biopsy-proven invasive lobular carcinoma
(ILC), preoperative MRI scan is considered (guid-
ance.nice.org.uk/cg80). This recommendation
reﬂects both the increased sensitivity of MRI, com-
pared with mammography and ultrasound, in
accurately assessing the size of the tumour and
identifying multiple invasive foci, particularly if the
patient has dense breasts, as well as the biology of
the ILC itself.1 2 Thus, accurate core biopsy assess-
ment is clinically important to ensure that patients
receive appropriate preoperative assessment and
resources are targeted correctly. There is, however,
very limited data on the accuracy of classiﬁcation of
ILC in core biopsy specimens;1 one study, for
example, records that of 500 carcinomas diagnosed
on needle core biopsy, there were 21 tumours diag-
nosed as ILC, of which 18 were diagnosed as the
same type in the surgical excision.3
MATERIAL AND METHODS
Eleven pathology laboratories from the UK and
Ireland submitted data to investigate the concord-
ance between core biopsies with a preoperative
diagnosis of ILC (either pure or mixed with another
subtype) with the subsequent surgical excision spe-
cimens. These were retrieved from each of the
department records through a search of the local
pathology computer systems, either through text or
SNOMED searches (depending on the unit) for ILC
diagnosed on needle core. Although an excel
spreadsheet was provided to be completed, some
units provided the raw data in this format, while
others provided the data in collated table format.
Those patients who had had preoperative systemic
treatment were excluded. Data on the size of the
core biopsy needle for sampling were not collected.
The audit period included cases from 2005 to 2011.
All forms of ILC were included (classical, alveo-
lar, tubulolobular, solid, pleomorphic or lobular
mixed). A tumour is regarded as being of mixed
type, for example, ILC and ductal/no special type
(IDC/NST), if unequivocal separate areas of both
morphological types are present and not if the
lesion shows indeterminate features. Aberrant
(absent or weak) E-cadherin staining is not a
requirement for diagnosis of ILC, and UK guide-
lines recommend that E-cadherin should not be
used to reclassify a tumour considered to be a
typical ILC on H&E stained sections.4 For this
reason, data on E-cadherin use were not collated,
although some units do use this immunomarker in
some selected cases, others more routinely and a
few pathologists in a very limited way, according to
personal preference. The aim of this audit was not
to assess the value of this assay.
RESULTS
In total, 1112 cases were submitted as showing fea-
tures of ILC or mixed ILC and IDC/NST/other
tumour types on needle core biopsy (range in case
numbers was 32–257 for the 11 units; average 101
cases per unit). Overall, of the 1112 cases, 928
were classiﬁed as pure ILC (83%) and 184 (17%)
as mixed ILC with another type on core biopsy. Of
the total 1112 cases, 844 were shown to be pure
ILC on surgical excision, 154 were mixed ILC+
another type (invariably IDC/NST) and 113 were
incorrectly categorised, and on excision were
shown to be IDC/NST (table 1).
Of those lesions categorised as pure ILC on core,
86% were indeed pure ILC on excision, 7% had a
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previously unrecognised, non-lobular component in addition to
the ILC on excision and 7% were pure IDC/NST. In essence,
therefore, 93% of these had an element of ILC correctly identi-
ﬁed in the core biopsy sample and could be considered concord-
ant. Of cores diagnosed as mixed ILC with another type on
core, complete agreement between core and excision (ie, both
bearing ILC+another type) was 46%, with 27% cases of pure
ILC, whilst 26% were IDC/NST in the surgical specimen. Thus,
agreement in lesions interpreted on core biopsy as ILC mixed
with another component was lower than those diagnosed as
pure ILC on core (although 73% had a lobular element present
in the former compared with 93% in the latter).
Concordance also varied by laboratory from 65% to 97% for
specimens with complete agreement between core and excision
(ie, core and excision––both pure ILC, or core and excision—
both mixed ILC and another type).
DISCUSSION
The aim of this study was not to explore the reproducibility of
the diagnosis and classiﬁcation of ILC, but to address the hist-
ology outcome for patients classiﬁed as having ILC on needle
core biopsy, irrespective of the depth of investigation. These
patients will potentially have an expensive MRI on the basis of
the histological diagnosis. For this reason, we did not address
the issue of number of ‘missed’ ILC on core biopsy. However,
one unit found that of 119 carcinomas categorised as classical
ILC in the excision specimen, 101 (84%) were called ILC in the
core and 10 (8%) were called mixed ILC and other type(s) in
the core, suggesting that there are not large numbers of patients
who are potentially missing the opportunity to beneﬁt from pre-
operative MRI breast imaging.
While the agreement in lesions interpreted on core biopsy as
ILC mixed with another component was lower (73%) than
those diagnosed as pure ILC on core (93%), the implications for
the use of preoperative breast MRI in this former group of
women is less clear. Indeed, of the 11 centres submitting data,
varying policies of preoperative MRI in the group of patients
with a core biopsy diagnosis of mixed ILC and another type are
applied, and this warrants further consideration.
Finally, although concordance varied by laboratory from 65%
to 97% for specimens with complete agreement between core
and excision (ie, core and excision––both pure ILC, or core and
excision––both mixed ILC plus another type), the aim of the
present audit was to examine routine practice in these UK and
Ireland laboratories. There was no major difference in concord-
ance between centres where cases were reported by monospecia-
lists and those where reporting was undertaken by more
generalists. It is also impossible to assess if immunohistochem-
ical (IHC) staining for E-cadherin contributed to the small varia-
tions in concordance seen, since both centres that more
routinely stain for E-cadherin on all biopsies suspicious of ILC
and centres that use IHC only in speciﬁc cases showed similarly
high agreement.
In conclusion, we have shown that 86% of cases of pure ILC
are correctly categorised on core biopsy samples, with another
7% having an unequivocal lobular component to their carcin-
omas (93% of total). These data indicate that there is not a
large excess of expensive MRIs being performed as a result of
histological categorisation.
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Table 1 Distribution of cases diagnosed as pure ILC or mixed ILC with another type on needle core biopsy by the 11 separate units
Unit
Core diagnosis of ILC Core diagnosis of ILC+other type
Total
cases per
unit
Cases with
complete
agreement (%)*
Excision
diagnosis
pure ILC
Excision
diagnosis ILC
+other type
Excision
diagnosis
IDC/NST Total
Excision
diagnosis
pure ILC
Excision
diagnosis ILC
+other type
Excision
diagnosis
IDC/NST Total
1 57 (75%) 3 (4%) 16 (21%) 76 2 (100%) 0 (0%) 0 (0%) 2 78 73
2 33 (87%) 4 (11%) 1 (3%) 38 0 (0%) 5 (71%) 2 (29%) 7 45 84
3 81 (98%) 2 (2%) 0 (0%) 83 7 (54%) 4 (31%) 2 (15%) 13 96 89
4 78 (95%) 3 (4%) 1 (1%) 82 2 (14%) 8 (57%) 4 (29%) 14 96 90
5 92 (93%) 5 (5%) 2 (2%) 99 3 (38%) 4 (50%) 1 (13%) 8 107 90
6 86 (94%) 4 (4%) 1 (1%) 91 0 (0%) 0 (0%) 0 (0%) 0 91 95
7 52 (91%) 4 (7%) 1 (2%) 57 8 (36%) 9 (41%) 5 (23%) 22 79 77
8 29 (97%) 1 (3%) 0 (0%) 30 0 (0%) 2 (100%) 0 (0%) 2 32 97
9 52 (91%) 0 (0%) 5 (9%) 57 0 (0%) 2 (40%) 3 (60%) 5 62 87
10 99 (74%) 14 (11%) 20 (15%) 133 5 (14%) 19 (53%) 12 (33%) 36 169 70
11 135 (74%) 29 (16%) 18 (10%) 182 23 (31%) 32 (43%) 20 (27%) 75 257 65
Total 794 (86%) 69 (7%) 65 (7%) 928 50 (27%) 85 (46%) 48 (26%) 184 1112 79
*Complete agreement here includes only those cases with absolute agreement, that is, cases categorised as pure ILC on both needle core biopsy and surgical excision and those
classified as mixed ILC with another type on both histological samples.
IDC/NST, invasive ductal carcinoma/no special type; ILC, invasive lobular carcinoma.
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